A phenotypic-transport model of selection and therapy-associated phenotypic redistribution in the VC-Resist glioblastoma state

Glioblastoma recurrence is sustained by tumour cells that survive chemoradiation and infiltrate the peritumoural brain. We previously identified VC-Resist, a Nestin-high, vessel-co-opting and therapy-resistant state induced by DNA-damaging therapy and vascular cues. Whether its short-term enrichment reflects selection of pre-existing cells, phenotypic redistribution, or both remains unclear because death, proliferation and state transitions co-occur. We formulate a phenotypic-transport model for glioblastoma-cell density along a continuous Nestin-reporter axis. The model separates phenotype-dependent net growth from conservative transport and is calibrated to seven-day flow-cytometric Nestin distributions after irradiation of MGG4 cells, with Sytox measurements informing treatment-associated death. It reproduces dose-dependent Nestin-high enrichment and is consistent with a graded association between higher Nestin expression, reduced proliferation and greater radiation resistance. Under the specified uncertainty ranges, transport parameters are among the strongest determinants of the modelled day-7 mean Nestin coordinate. Because the velocity field is inferred from the distributions being fitted, independent longitudinal data and transition-specific perturbations are needed to establish whether the redistribution depends causally on therapy-induced reprogramming. Counterfactual simulations compare attenuation of phenotypic transport with reduction of Nestin-associated protection. Our framework provides an interpretable, data-constrained basis for designing experiments that directly test therapy-induced plasticity in glioblastoma.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-18
DOI
https://doi.org/10.1038/s41598-026-80612-z
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A phenotypic-transport model of selection and therapy-associated phenotypic redistribution in the VC-Resist glioblastoma state

Gabriel F. Calvo, Carmen Ortega-Sabater, Giorgio Seano, Juan Jiménez-Sánchez et al.
Scientific Reports
Glioma Diagnosis and Treatment
article

A phenotypic-transport model of selection and therapy-associated phenotypic redistribution in the VC-Resist glioblastoma state

Gabriel F. Calvo, Carmen Ortega-Sabater, Giorgio Seano, Juan Jiménez-Sánchez, Cathy Pichol-Thievend, José Antonio Romero-Rosales, Juliette Reveilles
article en

Abstract

Glioblastoma recurrence is sustained by tumour cells that survive chemoradiation and infiltrate the peritumoural brain. We previously identified VC-Resist, a Nestin-high, vessel-co-opting and therapy-resistant state induced by DNA-damaging therapy and vascular cues. Whether its short-term enrichment reflects selection of pre-existing cells, phenotypic redistribution, or both remains unclear because death, proliferation and state transitions co-occur. We formulate a phenotypic-transport model for glioblastoma-cell density along a continuous Nestin-reporter axis. The model separates phenotype-dependent net growth from conservative transport and is calibrated to seven-day flow-cytometric Nestin distributions after irradiation of MGG4 cells, with Sytox measurements informing treatment-associated death. It reproduces dose-dependent Nestin-high enrichment and is consistent with a graded association between higher Nestin expression, reduced proliferation and greater radiation resistance. Under the specified uncertainty ranges, transport parameters are among the strongest determinants of the modelled day-7 mean Nestin coordinate. Because the velocity field is inferred from the distributions being fitted, independent longitudinal data and transition-specific perturbations are needed to establish whether the redistribution depends causally on therapy-induced reprogramming. Counterfactual simulations compare attenuation of phenotypic transport with reduction of Nestin-associated protection. Our framework provides an interpretable, data-constrained basis for designing experiments that directly test therapy-induced plasticity in glioblastoma.

Scientific Reports
Centre National de la Recherche Scientifique (FR), Inserm (FR), Spanish National Cancer Research Centre (ES), Servicio de Salud de Castilla La Mancha (ES), University of Castilla-La Mancha (ES), Institut Curie (FR)
Fondation ARC pour la Recherche sur le Cancer, Ministerio de Ciencia e Innovación, Junta de Comunidades de Castilla-La Mancha, European Regional Development Fund, Agencia Estatal de Investigación
Good health and well-being
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon